Featured Articles
 
FDA Approves Olaparib for HRR-Mutated Metastatic Castration-Resistant Prostate Cancer
Approximately 20% to 30% of men with metastatic castration-resistant prostate cancer have HRR gene mutation.
Read more
 
 
HIV PrEP Uptake Remains Low Among Teens
A new review in JAMA Pediatrics looks at the current status of PrEP uptake among adolescents aged 13 to 19 years who are at risk for HIV.
Read more
ADVERTISEMENT
Read More
 
Shingles a Risk Factor for Heart Attack and Stroke
Pharmacist, Technician Safety and Mental Health Amid COVID-19
Study: Heart Disease Risk Associated With Cognitive Decline
FDA OKs Atezolizumab for First-Line Treatment of PD-L1 High NSCLC